Lyfebulb and UnitedHealth Group Announce an Innovation Challenge for Patient Entrepreneurs with Inflammatory Bowel Disease
April 23, 2018 15:18 ET
|
Lyfebulb; UnitedHealth Group
MINNETONKA, Minn. and NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- Lyfebulb LLC and UnitedHealth Group (NYSE:UNH) invite patient entrepreneurs to compete in “Empowering Patients: An Innovation...
Vitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100
January 17, 2018 08:00 ET
|
Vitality Biopharma, Inc
LOS ANGELES, Jan. 17, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals,...
Immuron Commences US Non-Deal Institutional Investor Roadshow
August 15, 2017 09:15 ET
|
Immuron Limited
MELBOURNE, Australia, Aug. 15, 2017 (GLOBE NEWSWIRE) -- Australian microbiome biopharmaceutical company Immuron Limited (ASX:IMC) (NASDAQ:IMRN) is pleased to release to shareholders and investors...
Video Release -- Help Yourself While Helping Others: The Personal Benefits of Taking Steps for Crohn's Disease and Ulcerative Colitis
July 25, 2013 13:48 ET
|
Crohn's and Colitis Foundation of America
NEW YORK, July 25, 2013 (GLOBE NEWSWIRE) -- Known collectively as inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis affects 1 in 200 people. Whether you, or someone you...
Early Diagnosis and Public Awareness of Crohn's and Ulcerative Colitis Critical to Patient Care
November 23, 2011 09:00 ET
|
Crohn's & Colitis Foundation of Canada (CCFC)
TORONTO, ONTARIO--(Marketwire - Nov. 23, 2011) - Imagine experiencing agonizing and debilitating pain that lasts for hours, months and even a year without a Doctor or Medical Practitioner...